Spruce Biosciences to Participate in September Investor Conferences | Financial Buzz

Spruce Biosciences to Participate in September Investor Conferences

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that company management will participate in four upcoming investor conferences taking place virtually throughout the month of September:

  • H.C. Wainwright 23rd Annual Global Investment Conference

    Date:
    September 13 – 14, 2021

    Format: Company presentation (available September 13 at 7:00 am ET) and 1×1 meetings
  • Baird 2021 Global Healthcare Conference

    Date:
    September 14 – 15, 2021

    Format: Company presentation (September 15 at 1:25 pm ET) and 1×1 meetings
  • Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

    Date:
    September 20 – 22, 2021

    Format: Company presentation (September 21 at 11:35 am ET) and 1×1 meetings
  • SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines 1×1 Event

    Date:
    September 22 – 23, 2021

    Format: 1×1 meetings

Interested parties can access the webcast for each conference presentation from the Events section of the company’s investor relations website.

About Spruce Biosciences

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). Classic CAH is a serious and life-threatening disease with no known novel therapies approved in approximately 50 years. Spruce is also developing tildacerfont for women suffering from a rare form of polycystic ovary syndrome (PCOS) with primary adrenal androgen excess. To learn more, visit www.sprucebiosciences.com and follow us on Twitter @Spruce_Bio, LinkedIn, Facebook and YouTube.

Contacts

Media Contact

Will Zasadny

Canale Communications

(619) 961-8848

will.zasadny@canalecomm.com

media@sprucebiosciences.com

Investors

Xuan Yang

Solebury Trout

(415) 971-9412

xyang@soleburytrout.com

investors@sprucebiosciences.com

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!